Skip to main navigation Skip to search Skip to main content

Bone morphogenic protein-2 gene therapy for mandibular distraction osteogenesis

  • Russell L. Ashinoff
  • , Curtis L. Cetrulo
  • , Robert D. Galiano
  • , Michael Dobryansky
  • , Kirit A. Bhatt
  • , Daniel J. Ceradini
  • , Joseph Michaels V
  • , Joseph G. McCarthy
  • , Geoffrey C. Gurtner
  • , George A. Csank

Research output: Contribution to journalArticlepeer-review

Abstract

Distraction osteogenesis (DO) requires a long consolidation period and has a low but real failure rate. Bone morphogenic proteins (BMPs) accelerate bone deposition in fractures and critical-sized bone defects, but their effects on mandibular DO are unknown. We investigated the effect of local delivery of adenovirus containing the gene for BMP-2 (Adbmp-2) on mandibular DO in a rat model. Rats (n = 54) were distracted to 3 mm over 6 days. At the start of consolidation (POD 10), Adbmp-2 or adenovirus containing the lacZ gene (AdlacZ) was injected directly into the distraction zone. After 1, 2, and 4 weeks of consolidation, mandibles were evaluated for amount of bone deposition. Adbmp-2-treated specimens demonstrated an increased amount of new bone formation by radiographic, histologic, and histomorphometric analysis. This study demonstrates that local, adenovirally-mediated delivery of BMP-2 can increase bone deposition during DO, potentially shortening consolidation and enhancing DO in poorly healing mandibles, such as occurs postirradiation.

Original languageEnglish (US)
Pages (from-to)585-591
Number of pages7
JournalAnnals of Plastic Surgery
Volume52
Issue number6
DOIs
StatePublished - Jun 2004
Externally publishedYes

Keywords

  • BMP-2
  • Distraction osteogenesis
  • Gene therapy

ASJC Scopus subject areas

  • Surgery

Fingerprint

Dive into the research topics of 'Bone morphogenic protein-2 gene therapy for mandibular distraction osteogenesis'. Together they form a unique fingerprint.

Cite this